Incyte Corp
SEC CIK 879169 · INCY · last insider filing 2026-06-10
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Baker Julian | Director | filed 2006 - 2026 |
| Baker Felix | Director | filed 2008 - 2026 |
| Harrigan Edmund | Director | filed 2019 - 2026 |
| Brawley Otis W | Director | filed 2021 - 2026 |
| Bienaime Jean Jacques | Director | filed 2015 - 2026 |
| Baker Bros. Advisors LP | Director | filed 2012 - 2026 |
| Baker Brothers Life Sciences LP | Director | filed 2013 - 2026 |
| Fouse Jacqualyn A | Director | filed 2017 - 2026 |
| Clancy Paul J | Director | filed 2015 - 2026 |
| 667, L.P. | Director | filed 2013 - 2026 |
| Baker Bros. Advisors (GP) LLC | Director | filed 2013 - 2026 |
| High Katherine A | Director | filed 2020 - 2026 |
| Meury William | Director · Chief Executive Officer | filed 2025 - 2026 |
| Hoppenot Herve | Director · Special Advisor to the CEO | filed 2014 - 2025 |
| Schaffert Susanne | Director | filed 2022 - 2025 |
| Dixon Wendy L | Director | filed 2010 - 2022 |
| Friedman Paul A | Director · Chief Executive Officer | filed 2006 - 2020 |
| Brooke Paul A | Director | filed 2006 - 2020 |
| 14159, L.P. | Director | filed 2013 - 2019 |
| Ariko Barry A | Director | filed 2006 - 2015 |
| DE Schutter Richard U | Director | filed 2006 - 2015 |
| Whitfield ROY A | Director | filed 2006 - 2014 |
| FBB Associates | Director | filed 2012 - 2012 |
| FBB2 LLC | Director | filed 2012 - 2012 |
| Baker Brothers Life Sciences Capital (GP), LLC | Director | filed 2007 - 2012 |
| 14159 Capital (GP), LLC | Director | filed 2007 - 2012 |
| Baker Bros. Capital (GP), LLC | Director | filed 2007 - 2011 |
| Niblack John F | Director | filed 2006 - 2011 |
| Baker Biotech Capital (GP), LLC | Director | filed 2007 - 2010 |
| Baker / Tisch Capital (GP), LLC | Director | filed 2007 - 2010 |
| Emmens Matthew | Director | filed 2006 - 2008 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Tray Thomas | Principal Accounting Officer | filed 2022 - 2026 |
| Cagnoni Pablo J | President, R&D | filed 2023 - 2026 |
| Stein Steven H | EVP & Chief Medical Officer | filed 2016 - 2026 |
| Upadhyay Suketu | EVP & Chief Financial Officer | filed 2026 - 2026 |
| Trotta Matteo | EVP, GM, Dermatology US | filed 2024 - 2026 |
| Morrissey Michael James | EVP, Head of Tech. Operations | filed 2019 - 2026 |
| Heeson Lee | EVP, Head of Incyte Intl | filed 2024 - 2026 |
| Issa Mohamed Khairie | EVP, Head of US Oncology | filed 2025 - 2026 |
| Mayes Patrick A | EVP & Chief Scientific Officer | filed 2025 - 2026 |
| Hoffman Richard A. | EVP & General Counsel | filed 2025 - 2025 |
| Denton Sheila A. | EVP & General Counsel | filed 2023 - 2025 |
| Gardner David H | EVP, Chief Strategy Officer | filed 2025 - 2025 |
| Basi Ramitpal K | EVP, Human Resources | filed 2025 - 2025 |
| Flannelly Barry P | See Remarks | filed 2014 - 2025 |
| Iyengar Vijay K | EVP, GMAPPS | filed 2016 - 2025 |
| Swain Paula J | EVP, Human Resources | filed 2006 - 2025 |
| Stamoulis Christiana | EVP & Chief Financial Officer | filed 2019 - 2025 |
| Dickinson Jonathan Elliott | EVP, General Manager, Europe | filed 2019 - 2024 |
| Pasquale Maria E | EVP & General Counsel | filed 2018 - 2023 |
| Dhanak Dashyant | EVP & Chief Scientific Officer | filed 2018 - 2023 |
| Trower Paul | VP, Finance & Prin Acc Officer | filed 2015 - 2022 |
| Wenqing Yao | Ex VP Discovery Medicinal Chem | filed 2014 - 2021 |
| Gryska David W | Executive Vice President, CFO | filed 2014 - 2018 |
| Huber Reid M | Exec VP & Chief Scientific Off | filed 2014 - 2018 |
| Siegel Eric H. | EVP, General Counsel | filed 2011 - 2017 |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | filed 2009 - 2016 |
| Daly James M | Exec. VP & Chief Comm. Officer | filed 2012 - 2015 |
| Chardonnet Laurent | VP Finance and Treasurer | filed 2006 - 2015 |
| Hastings David C | Chief Financial Officer | filed 2006 - 2014 |
| Andrews Patricia S | Chief Commercial Officer | filed 2008 - 2012 |
| Schreck Patricia A | EVP, General Counsel | filed 2006 - 2011 |
| Metcalf Brian W | Chief Drug Discovery Scientist | filed 2006 - 2011 |
| Friedman Steven M. | EVP, Biology & Preclinical Dev | filed 2009 - 2010 |
| Keller John A | Chief Business Officer | filed 2006 - 2008 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.